Boron in My Mind: A Comprehensive Review of the Evolution of the Diverse Syntheses of 4‐Borono‐ l ‐Phenylalanine, the Leading Agent for Boron Neutron Capture Therapy
ChemMedChem · 2025
DOI: 10.1002/cmdc.202500059 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift ChemMedChem, 2025. Verfasst von Sarfraz Ahmad und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and Biochemistry, University of Windsor, Windsor, ON, N9B 3P4, Canada. Hauptthemen laut MEDLINE: Boron Neutron Capture Therapy, Phenylalanine, Boron Compounds, Boron. Die Arbeit nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Natural Sciences and Engineering Research Council of Canada.
Abstract (Originalsprache)
Boron neutron capture therapy leverages the nuclear reaction between boron‐10 and thermal neutrons to selectively destroy cancer cells while minimizing damage to surrounding healthy tissues. This therapy finds use in treating glioblastoma, which, as a brain cancer, is difficult to treat using conventional radiotherapy, surgery, and chemotherapy due to location and the risk of brain damage. However, to work, the cells must contain 10 B. 4‐Borono‐ l ‐phenylalanine ( l ‐BPA) is the most frequently used boron delivery agent in this therapy. Surprisingly, despite its seemingly simple structure, there is no consensus approach to making it—the synthesis of l ‐BPA has been approached through multiple routes, reflecting the challenges in producing high‐purity, isotopically enriched material. When a new site is looking to make this essential material, it can be challenging to determine the best route for the situation as there is no critical analysis comparing and discussing the relative merits of the approaches. Herein, the reported methods, from both the academic and patent literature, used to synthesize l ‐BPA, are comprehensively and critically examined and compared. The review also highlights the limitations of each method regarding scalability, cost‐effectiveness, and safety, especially considering the high cost of isotopically enriched 10 B.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry and Biochemistry, University of Windsor, Windsor, ON, N9B 3P4, Canada.
- Windsor Regional Hospital, Windsor, ON, N8W 1L9, Canada.
- Department of Biomedical Sciences, University of Windsor, Windsor, ON, N9B 3P4, Canada.
- WE-Spark Health Institute, Windsor, ON, N9B 3P4, Canada.
- Lawson Research Institute, St. Joseph's Health Care London, London, ON, N6C 2R5, Canada.
- Binary Star Research Services, Windsor, ON, N9J 3X8, Canada.
ORCID-Profile: Sarfraz Ahmad, Ming Pan, John J Hayward, Lisa A Porter, John F Trant
Förderung
- Natural Sciences and Engineering Research Council of Canada
Zitieren
APA
Ahmad, S., Pan, M., Hayward, J. J., Sementilli, M., Porter, L. A., & Trant, J. F. (2025). Boron in My Mind: A Comprehensive Review of the Evolution of the Diverse Syntheses of 4‐Borono‐ l ‐Phenylalanine, the Leading Agent for Boron Neutron Capture Therapy. ChemMedChem. https://doi.org/10.1002/cmdc.202500059
Vancouver
Ahmad S, Pan M, Hayward JJ, Sementilli M, Porter LA, Trant JF. Boron in My Mind: A Comprehensive Review of the Evolution of the Diverse Syntheses of 4‐Borono‐ l ‐Phenylalanine, the Leading Agent for Boron Neutron Capture Therapy. ChemMedChem. 2025. doi:10.1002/cmdc.202500059
BibTeX
@article{Ahmad2025,
author = {Ahmad, Sarfraz and Pan, Ming and Hayward, John J and Sementilli, Massimo and Porter, Lisa A and Trant, John F},
title = {Boron in My Mind: A Comprehensive Review of the Evolution of the Diverse Syntheses of 4‐Borono‐ l ‐Phenylalanine, the Leading Agent for Boron Neutron Capture Therapy},
journal = {ChemMedChem},
year = {2025},
doi = {10.1002/cmdc.202500059}
}
EUVIMED